Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Remicade (infliximab) - Important safety information from Centocor and Schering Plough as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
07/06/2006
Problem Or Issue:
Please find attached important safety communication regarding cases of hepatosplenic T-cell lymphoma in adolescent and young adult patients with Crohn's disease treated with Remicade (infliximab)
« Back
Date Printed: 26/04/2024